Product News and Recalls

Xarelto Bellwether Cases Inch Closer to Court Dates

more xarelto cases set for trialIn 2011, the FDA approved a drug that many hoped would be the first step forward in blood thinning medication since Coumadin’s debut in the 1960s: Xarelto.

Created by Johnson & Johnson and Bayer, Xarelto has been responsible for over $3.2 billion in profits for its manufacturers and developers. It has also become Bayer’s top-selling medication ever. Yet despite its successes on paper, the reality is that more than 18,000 plaintiffs ...

continue reading...

Breast Implants and Cancer: Here’s What We Know

textured implants potentially linked to breast cancerA new wave of reports of breast cancers linked to breast augmentation and implants has women scrambling to learn more. So far, here’s what we know.

First, nearly every case of the cancer in question has been linked to textured implants. That should be the first step in determining any course of action. And, it’s worth noting that most of the implants used in the United States are smooth. If you ...

continue reading...

New Alerts Over Invokana Amputations

invokana increases risk of amputationsThose who suffer from Type II diabetes are well aware of the risks their disease brings. Medical professionals repeatedly emphasize the importance of keeping up with blood glucose levels, regulating the diet, and exercising. The outcomes of maintaining such vigilance are stark in their contrast. Comply, and you can live a fairly normal life. Fail to comply, however, and the consequences can be tragic.

Amputation; generally of the leg or foot, is among ...

continue reading...

Litigation Continues Over Defective Johnson & Johnson Transvaginal Mesh

transvaginal mesh lawsuits continueJohnson & Johnson and their Ethicon unit face another defective medical device lawsuit in Philadelphia over their transvaginal mesh products. Sharon Beltz claims that she was injured by a pelvic mesh device because of alleged oversights in the manufacturing process. Opening statements have taken place in the city’s Court of Common Pleas.

Nearly five years ago, Johnson & Johnson voluntarily pulled four lines of mesh products from shelves after facing ...

continue reading...

FDA Issues New Warning for Opioid Painkillers for Children

FDA strengthens warnings on opioids for childrenThe New York Times reports that the FDA has strengthened its warnings for opioid medications for children. Specifically, they advise that those 12 and younger are not to take codeine, while those 18 and younger should not take tramadol after certain types of surgery. In addition, nursing mothers are advised to avoid both drugs because they could impact breastfeeding.

As the strongest type of warning levied by ...

continue reading...

Trouble for Diabetes Drug Makers?

invokana and farxiga mdls to move forwardKnown as SGLT2 inhibitors for short, sodium glucose co-transporter 2 inhibitors are a class of drugs intended for certain individuals with Type II diabetes. The drugs prevent glucose from being absorbed in the kidneys and reduce glucose in the blood by causing it to be expelled in the urine.

Unfortunately, this relatively new class of drugs has already allegedly caused enough harm to warrant FDA action ...

continue reading...
Page 2 of 301 12345...»